A mini-review published August 7, 2026 in the journal Frontiers in Nutrition summarizes current research on the relationship between diet and Alzheimer's. According to the review, observational study evidence suggests adherence to certain dietary patterns, including Mediterranean and MIND diets, correlates with lower Alzheimer's risk and slower cognitive decline, while randomized controlled trial evidence remains less consistent.
The scale of the problem worldwide
Globally, approximately 50 million people over 65 lived with dementia in 2021, as the review notes citing earlier surveys. This number tripled between 1990 and 2021 and is projected to triple again by 2050. Alzheimer's is the most common dementia form, accounting for approximately two-thirds of diagnoses in people over 65. Between 60 and 80 percent of Alzheimer's risk is genetic; over 40 susceptibility loci have been identified, with APOE gene variants showing the strongest association with disease risk. Simultaneously, the authors estimate that 40 percent of dementia cases could be prevented through twelve modifiable risk factors, including education level, hearing loss, hypertension, obesity, diabetes, smoking, depression, social isolation, and physical inactivity.
Mediterranean diet in large observational studies
A meta-analysis cited in the review combining 21 studies with 65,955 participants linked higher Mediterranean diet adherence with an odds ratio of 0.89 (95-percent confidence interval 0.84 to 0.94). In 38,292 participants with Alzheimer's, the odds ratio was 0.73 (0.62 to 0.85). Another meta-analysis of 23 studies found a hazard ratio of 0.82 for cognitive impairment in people with high Mediterranean diet adherence. For dementia the value was 0.89, for Alzheimer's 0.70. According to the review, WHO guidelines recommend a Mediterranean diet to reduce risk of cognitive decline or dementia because it helps and causes no harm.
Randomized studies show a different picture
In prospective cohort studies, the DASH diet showed no consistent cognitive benefits. In the only relevant randomized trial, it provided no independent improvements in memory, executive function, or global cognition, though combined with aerobic training it did. A randomized controlled study with over 600 older adults found no significant cognitive advantage of the MIND diet versus calorie-matched control diet after three years of follow-up.
Meat, inflammation, and individual risk factors
According to the review, increased meat consumption is associated with higher Alzheimer's risk, as are Western diets high in ultra-processed foods, refined carbohydrates, saturated and trans fats, and salt. All six identified observational studies on pro-inflammatory dietary patterns reported worse cognitive outcomes. The Rotterdam Study showed people with diabetes have nearly twice the risk of developing Alzheimer's. The VITACOG trial found that vitamin B supplementation slowed brain atrophy progression in mild cognitive impairment, with cognitive benefits most evident when sufficient omega-3 status was also present.
Foundation for planned meta-analysis
The authors criticize the field for consistently depicting the diet-Alzheimer's relationship as direct association while neglecting biological pathways and individual factors. The mini-review itself was developed as conceptual foundation for a planned meta-analysis and summarizes current knowledge on key pathways including neuroinflammation, brain insulin resistance, oxidative stress, blood-brain barrier dysfunction, hyperhomocysteinemia, and gut-brain axis dysfunction.
For those affected and their families, this means primarily: evidence comes mainly from observational studies showing an association. Randomized trials of individual diets have so far shown inconsistent or no independent effects.